SPH Phililab  received acceptance letters from the FDA on its ANDA submissions for Colesevelam Hydrochloride Tablet,625 mg and Colesevelam Hydrochloride for Oral Suspension, 3.75 g (for Shanghai Pharmaceuticals).

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt